ClinicalTrials.Veeva

Menu

Prevalence, Severity and Natural Course of Sleep Apnea After Cardiac Surgery (SDB-ZRW)

Z

Zürcher RehaZentrum Wald

Status

Unknown

Conditions

Sleep Disordered Breathing

Treatments

Other: screening

Study type

Observational

Funder types

Other

Identifiers

NCT02632162
ZRW-SDB-2015

Details and patient eligibility

About

Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months.

Full description

Objective(s) of the project

  • Evaluate the prevalence of sleep apnea after cardiac surgery
  • Compare results interindividually (group A vs. group B) and intraindividually (longitudinal assessment after 3 months)

Outcome(s)

  • Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery
  • composite endpoint of events at 3 months (cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, revascularisation procedure, new atrial fibrillation and stroke)
  • change in 6-minute walking test (6-MWT)
  • impact of heart surgery on sleep apnoe

Enrollment

450 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cardiac surgery or orthopedic surgery <2 weeks

Exclusion criteria

  • known SDB

Trial design

450 participants in 2 patient groups

cardiac surgery
Description:
active Group screening
Treatment:
Other: screening
orthopedic surgery
Description:
control Group screening
Treatment:
Other: screening

Trial contacts and locations

1

Loading...

Central trial contact

Matthias Hermann, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems